What is the highest recommended amoxicillin dose for children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Highest Recommended Amoxicillin Dose in Children

For severe infections and pneumococcal coverage, the highest recommended amoxicillin dose in children is 90 mg/kg/day divided every 12 hours, which can exceed typical adult maximum doses in larger children and is explicitly endorsed by current guidelines. 1

Standard Dosing Framework by Severity

Mild-to-Moderate Infections

  • For uncomplicated ear/nose/throat infections, skin infections, and genitourinary tract infections, the FDA-approved dosing is 25 mg/kg/day divided every 12 hours or 20 mg/kg/day divided every 8 hours 2
  • This lower-dose regimen is appropriate for infections caused by susceptible organisms without resistance concerns 3

Severe Infections and Lower Respiratory Tract Infections

  • High-dose amoxicillin at 80–90 mg/kg/day divided every 12 hours is the recommended first-line treatment for severe acute otitis media, community-acquired pneumonia, and infections requiring enhanced pneumococcal coverage 3, 1, 2
  • The FDA label explicitly states 45 mg/kg/day divided every 12 hours or 40 mg/kg/day divided every 8 hours for severe infections and all lower respiratory tract infections in children weighing less than 40 kg 2

Maximum Dosing for Resistant Pneumococcal Infections

Highest Guideline-Endorsed Dose

  • For Streptococcus pneumoniae with penicillin MIC >2.0 µg/mL, the recommended dose is 90 mg/kg/day divided every 12 hours 1
  • In a 28 kg child, this translates to approximately 1,260 mg per dose twice daily—substantially exceeding the typical adult maximum dose of 875 mg 1
  • Clinicians must not cap amoxicillin at adult maximum doses (e.g., 500 mg or 875 mg twice daily) in children requiring weight-based dosing, as this leads to systematic underdosing in larger children 1, 4

Evidence Supporting High-Dose Therapy

  • High-dose amoxicillin achieves middle ear fluid levels that exceed the minimum inhibitory concentration for intermediately resistant pneumococcal serotypes (penicillin MIC 0.12–1.0 µg/mL) and many highly resistant serotypes (MIC ≥2 µg/mL) 3
  • Studies demonstrate superior bacteriologic eradication rates with high-dose amoxicillin-clavulanate (96% for S. pneumoniae) compared to alternative agents 3

Critical Dosing Pitfall: The Weight-Based Dosing Gap

Documented Underdosing in Larger Children

  • A retrospective study of 3,620 pediatric encounters revealed that children above 15 kg routinely receive doses capped at adult maximums, resulting in most patients above 60 kg receiving less than 40 mg/kg/day 4
  • Linear regression demonstrated a significant negative correlation between weight and mg/kg/day dosing, with older/larger children systematically underdosed 4
  • This practice contradicts guideline recommendations and may contribute to treatment failure in infections requiring high-dose therapy 1, 4

Special Population: Neonates and Young Infants

Infants Under 3 Months

  • Due to incompletely developed renal function, the maximum recommended dose is 30 mg/kg/day divided every 12 hours 2
  • This lower ceiling reflects pharmacokinetic limitations in this age group and should not be exceeded 2

When to Escalate Beyond Standard High-Dose Amoxicillin

Second-Line Therapy Indications

  • If no clinical improvement occurs after 48–72 hours of standard amoxicillin therapy, escalate to high-dose amoxicillin-clavulanate (80–90 mg/kg/day of the amoxicillin component) to cover β-lactamase-producing Haemophilus influenzae and Moraxella catarrhalis 3, 5, 1
  • The recommended formulation is the 14:1 ratio (amoxicillin to clavulanate) to minimize diarrhea 3

Atypical Pathogen Coverage

  • For children >3 years of age with suspected atypical pathogens (Mycoplasma pneumoniae, Chlamydophila pneumoniae), add a macrolide (e.g., erythromycin 50 mg/kg/day in four divided doses for 7 days) to the existing amoxicillin regimen 5, 1

Practical Dosing Example for a Large Child

28 kg Child Requiring High-Dose Therapy

  • 90 mg/kg/day regimen: approximately 1,260 mg per dose twice daily (≈25.2 mL of 250 mg/5 mL suspension) 1
  • 45 mg/kg/day alternative: approximately 630 mg per dose twice daily if using the lower end of the high-dose range 1, 2
  • These doses significantly exceed the adult maximum of 875 mg twice daily but are necessary to achieve therapeutic drug levels in severe infections 1

Duration of Therapy

Standard Treatment Course

  • Continue treatment for a minimum of 48–72 hours beyond clinical improvement or evidence of bacterial eradication 2
  • For Streptococcus pyogenes infections (e.g., pharyngitis), a minimum 10-day course is mandatory to prevent acute rheumatic fever 1, 2

Recent Evidence on Duration

  • A 2021 factorial non-inferiority trial (CAP-IT) demonstrated that 3-day treatment was non-inferior to 7 days for community-acquired pneumonia in children discharged from emergency departments, though cough resolution was slightly faster with 7-day treatment 6, 7
  • However, this finding applies to uncomplicated pneumonia in children already improving; severe infections still warrant longer courses 6, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.